Skip to content
FDA weighs first-ever OTC birth control pill episode artwork

Jul 13, 2022 10 min

FDA weighs first-ever OTC birth control pill

from Decoded by POLITICO Hosted by POLITICO

The Food and Drug Administration is reviewing a first-of-its-kind application from HRA Pharma for Opill. If green-lit by the agency, Opill would become the first daily, hormonal birth control pill sold without a prescription. The submission of the application follows more than six years of studies the company has run. Alice Miranda Ollstein reports.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

FDA weighs first-ever OTC birth control pill

0:00 10:23

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Decoded by POLITICO?

This episode is 10 minutes long.

When was this Decoded by POLITICO episode published?

This episode was published on July 13, 2022.

Can I download this Decoded by POLITICO episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.